Berend Jan Bosch

Title: Berend Jan Bosch: Innovator in Immunology and Vaccine Development

Introduction

Berend Jan Bosch is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of immunology, particularly in vaccine development. His innovative work focuses on creating immunogenic compositions that can enhance the effectiveness of vaccines.

Latest Patents

Bosch holds a patent for "Immunogenic compositions in particulate form and methods for producing the same." This invention relates to the development of vaccines based on native antigen oligomers. The patent describes an immunogenic composition in particulate form, which includes oligomers of a surface-exposed polypeptide of pathogenic or tumor origin. These oligomers are bound non-covalently to a particulate carrier, along with a pharmaceutically acceptable diluent or excipient. Additionally, the invention provides a recombinant polypeptide that comprises an antigenic domain fused to an oligomerization domain, which is further linked to a peptidoglycan binding domain capable of mediating the non-covalent attachment of the polypeptide to a non-viable bacterium-like particle obtained from a Gram-positive bacterium.

Career Highlights

Berend Jan Bosch is associated with Mucosis B.V., a company that focuses on innovative vaccine development. His work at Mucosis has allowed him to explore new avenues in immunology and contribute to advancements in vaccine technology.

Collaborations

Bosch has collaborated with notable colleagues such as Cornelis Johannes Leenhouts and Bert Jan Haijema. These collaborations have further enriched his research and development efforts in the field of immunology.

Conclusion

Berend Jan Bosch is a prominent figure in the realm of immunology and vaccine innovation. His patent and work at Mucosis B.V. highlight his commitment to advancing vaccine technology for better health outcomes.